Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, placebo-controlled study comparing formoterol-beclometason 12/200
mcg BID versus placebo to evaluate the clinical effect on coughing in patients with
non-cystic fibrosis (non-CF) bronchiectasis, native to inhaled corticosteroid (ICS) therapy
and no history of asthma or chronic obstructive pulmonary disease (COPD)